Evidence map›Paper›PMID 22198749›Full record

ReviewFrontiers of medicine2011

Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.

Liangqian Tong, Ming Zhao, Shu Zhu, Jing Chen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Frontiers of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Engineering copper ferrite (CuFeMicrosystems & nanoengineering · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Toxicological Aspects of Iron Oxide Nanoparticles.Advances in experimental medicine and biology · 2022
    Article
  6. Article
  7. Neurotheranostics as personalized medicines.Advanced drug delivery reviews · 2019
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Clinically Approved Nanoparticle Imaging Agents.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2016
    Review
  13. Ligand-targeted theranostic nanomedicines against cancer.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liangqian TongDepartment of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Ming Zhao
Shu Zhu
Jing Chen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superparamagnetic iron oxide (SPIO) nanoparticles have become a popular strategy of cancer treatment and molecular imaging because of their versatile properties and biocompatibility. A variety of studies have shown the exciting potential of functionalized SPIO nanoparticles, such as surface-coated, targeted ligandconjugated, and/or drug-loaded SPIO nanoparticles, as powerful tools for targeted imaging and therapy. Moreover, the applications of SPIO nanoparticles that integrate diagnosis and therapy in SPIO nanoparticles facilitate the monitoring of therapeutic efficacy during treatment. In the present review, we primarily concentrate on the recent advancements in the field of SPIO nanoparticles in terms of synthesis, targeted therapy, and cancer imaging.

Indexed as

Magnetite NanoparticlesAntineoplastic AgentsContrast MediaHumansMolecular ImagingMolecular Targeted TherapyNeoplasmsAntineoplastic AgentsContrast MediaMagnetite Nanoparticles

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.